{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} A Review of COVID-19 Chilblains-like Lesions and their Differential Diagnosis
Activity Steps
Description
Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Purpose of Activity
To familiarize wound care practitioners with the differential diagnoses of chilblains-like lesions that could be associated with the complications of COVID-19.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the population most often affected by COVID toes.
- Select the assessments that help differentiate the various conditions that cause chilblains-like lesions.
- Choose appropriate treatment options for the various conditions that cause chilblains-like lesions.
Disclosures
Dr Lara-Corrales is part of the Pediatric Dermatology Research Alliance COVID-19 Response Task Force, a collaboration between the Society for Pediatric Dermatology and the Pediatric Dermatology Research Alliance. She has also disclosed ongoing financial relationships with Abbvie & Sanofi Genzyme as well as past relationships with Johnson & Johnson, Avicanna, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, Pierre Fabre, Regeneron, Clementia, and Valeant. Dr Sibbald has disclosed past financial relationships with Novartis, Pfizer & Sanofi Genzyme. The remaining authors, faculty, staff, and planners in any position to control the content of this CME/NCPD activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.
Lippincott CME Institute has identified and resolved all conflicts of interest concerning this educational activity.Credits:
- ACCME 1.0 CME